Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Dec;33(12):507-527.
doi: 10.1089/apc.2019.0119.

HIV Pre-Exposure Prophylaxis Implementation Cascade Among Health Care Professionals in the United States: Implications from a Systematic Review and Meta-Analysis

Affiliations
Meta-Analysis

HIV Pre-Exposure Prophylaxis Implementation Cascade Among Health Care Professionals in the United States: Implications from a Systematic Review and Meta-Analysis

Chen Zhang et al. AIDS Patient Care STDS. 2019 Dec.

Abstract

Although pre-exposure prophylaxis (PrEP) has been approved for primary HIV prevention for individuals aged 18 years or older since 2012, PrEP utilization has been suboptimal. To understand trends in PrEP provision from the health care providers' perspective, we systematically assessed each specific stage along the PrEP implementation cascade (i.e., awareness, willingness, consultation, and prescription) among health care professionals (HCPs) in the United States. Between June and December 2018, we conducted a systematic review of published studies on this topic. A total of 36 eligible studies were identified and included in the analyses. Random-effect models were employed to examine the pooled prevalence of each key stage along the cascade. Time trend and subgroup analyses were conducted. A thematic analysis was used to identify barriers and facilitators along the PrEP cascade. In this study, a total of 18,265 HCPs representing diverse demographics were included. The pooled prevalence of PrEP awareness was 68% [95% confidence interval (CI) = 55-80%], willingness to prescribe PrEP was 66% (95% CI = 54-77%), PrEP consultation was 37% (95% CI = 25-51%), and prescription provision was 24% (95% CI = 17-32%). Subgroup analyses revealed that PrEP provision among HCPs was lowest in the south, but has been improving annually nationwide. Infectious disease specialists [odds ratio (OR) = 4.06, 95% CI = 3.12-5.28; compared with primary care providers] and advanced practice registered nurses/physician assistants (OR = 1.51, 95% CI = 1.09-2.09; compared with physicians) had higher odds of prescribing PrEP. Barriers and facilitators regarding optimal PrEP implementation were embedded within individual, dyadic, social, and structural levels. This meta-analysis has comprehensively examined the trend and pattern of PrEP implementation among HCPs. To achieve optimal implementation of the PrEP cascade in the United States, tailored training and programs need to be provided to HCPs.

Keywords: PrEP implementation cascade; United States; health care professionals; meta-analysis; systematic review.

PubMed Disclaimer

Conflict of interest statement

No competing financial interests exist.

Figures

FIG. 1.
FIG. 1.
PrEP care implementation among health care professionals by different locations in the United States. Midwest has very limited number of studies. Standard errors are presented to illustrate the variance across different variables. PrEP, pre-exposure prophylaxis.
FIG. 2.
FIG. 2.
PrEP care implementation among health care professionals in the United States (by year). A series of trend tests using “ntrend” command have been used. The trend tests showed PrEP awareness across years is insignificant (z = 0.29; p = 0.771); PrEP willingness across year is insignificant (z = 1.85, p = 0.065); PrEP consultation across year is insignificant (z = 1.20, p = 0.229); PrEP prescription across year is significant (z = 2.96, p = 0.003). Standard errors are presented to illustrate the variance across different variables.

Similar articles

Cited by

References

    1. Centers for Disease Control and Prevention (CDC). HIV in the United States and Dependent Areas. Atlanta, GA: CDC; 2019
    1. Centers for Disease Control and Prevention (CDC). Diagnoses of HIV Infection in the United States and Dependent Areas. Atlanta, GA: CDC, 2017. 2018
    1. Centers for Disease Control and Prevention (CDC). HIV Prevention Works. 2017. Available at: www.cdc.gov/hiv/policies/hip/works.html (Last accessed September5, 2019).
    1. Baeten JM, Donnell D, Ndase P, et al. . Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012;367:399–410 - PMC - PubMed
    1. Delaugerre C, Antoni G, Mahjoub N, et al. . Assessment of HIV screening tests for use in preexposure prophylaxis programs. J Infect Dis 2017;216:382–386 - PubMed

Publication types

MeSH terms

Substances